Development and validation of a Clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
BACKGROUND: Angiotensin-converting enzyme inhibitors are effective for many cardiovascular diseases and are widely prescribed, but cough sometimes necessitates their withdrawal.
OBJECTIVE: To develop and validate a model that predicts, by using information available at first prescription, whether a patient will develop cough within 6 months.
DESIGN: Retrospective cohort study with derivation and validation sets.
SETTING: Outpatient clinics affiliated with an urban tertiary care hospital.
PATIENTS: Clinical data were collected from electronic charts. The derivation set included 1,125 patients and the validation set included 567 patients.
MEASUREMENTS: Angiotensin-converting enzyme inhibitor-induced cough assessed by predetermined criteria.
RESULTS: In the total cohort, 12% of patients developed angiotensin-converting enzyme inhibitor-induced cough. Independent multivariate predictors of cough were older age, female gender, non-African American (with East Asian having highest risk), no history of previous angiotensin-converting enzyme inhibitor use, and history of cough due to another angiotensin-converting enzyme inhibitor. Patients with a history of angiotensin-converting enzyme inhibitor-induced cough were 29 times more likely to develop a cough than those without this history. These factors were used to develop a model stratifying patients into 4 risk groups. In the derivation set, low-risk, average-risk, intermediate-risk, and high-risk groups had a 6%, 9%, 22%, and 55% probability of cough, respectively. In the validation set, 4%, 14%, 20%, and 60% of patients in these 4 groups developed cough, respectively.
CONCLUSIONS: This model may help clinicians predict the likelihood of a particular patient developing cough from an angiotensin-converting enzyme inhibitor at the time of prescribing, and may also assist with subsequent clinical decisions.
- Khalil, ME, Basher, AW, Brown, EJ, Alhaddad, IA (2001) A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol 37: pp. 1757-64 CrossRef
- Halkin, A, Keren, G (2002) Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease. Am J Med 112: pp. 126-34 CrossRef
- Cherry, DK, Woodwell, DA (2002) National Ambulatory Medical Care Survey: 2000 Summary. Advance Data from Vital and Health Statistics; No. 328. National Center for Health Statistics, Hyattsville, Md
- Sebastian, JL, McKinney, WP, Kaufman, J, Young, MJ (1991) Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. Chest 99: pp. 36-9
- Simon, SR, Black, HR, Moser, M, Berland, WE (1992) Cough and ACE inhibitors. Arch Intern Med 152: pp. 1698-700 CrossRef
- Israili, ZH, Hall, WD (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 117: pp. 234-42
- Smyrnios, NA, Irwin, RS, Curley, FJ, French, CL (1998) From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults. Arch Intern Med 158: pp. 1222-8 CrossRef
- Gandhi, TK, Burstin, HR, Cook, EF (2000) Drug complications in outpatients. J Gen Intern Med 15: pp. 149-54 CrossRef
- Grossman, E, Messerli, FH, Neutel, JM (2000) Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?. Arch Intern Med 160: pp. 1905-11 CrossRef
- Speirs, C, Wagniart, F, Poggi, L (1998) Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients. Br J Clin Pharmacol 46: pp. 63-70 CrossRef
- Moore, N, Noblet, C, Joannides, R, Ollagnier, M, Imbs, JL, Lagier, G (1993) Cough and ACE inhibitors. Lancet 341: pp. 61-61 CrossRef
- Os, I, Bratland, B, Dahlof, B, Gisholt, K, Syvertseri, JO, Tretli, S (1994) Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 7: pp. 1012-5
- Elliott, WJ (1996) Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther 60: pp. 582-8 CrossRef
- Kostis, JB, Shelton, B, Gosselin, G (1996) Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J 131: pp. 350-5 CrossRef
- Woo, KS, Norris, RM, Nicholls, G (1995) Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 75: pp. 967-8 CrossRef
- Ishimitsu, T, Yagi, S, Ebihara, A (1997) Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension. Jpn Heart J 38: pp. 831-40
- Ajayi, AA, Adigun, AQ (2000) Angioedema and cough in Nigerian patients receiving ACE inhibitors. Br J Clin Pharmacol 50: pp. 81-2 CrossRef
- Malini, PL, Strocchi, E, Fiumi, N, Ambrosioni, E, Ciavarella, A (1999) ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care 22: pp. 1586-7 CrossRef
- Lee, YJ, Chiang, YF, Tsai, JC (2000) Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor. Diabetes Care 23: pp. 427-8 CrossRef
- Keane, WF, Polis, A, Wolf, D, Faison, E, Shahinfar, S (1997) The long-term tolerability of enalapril in hypertensive patients with renal impairment. Nephrol Dial Transplant 12: pp. 75-81
- Gilchrist, NL, Richards, AM, March, R, Nicholls, MG (1989) Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 3: pp. 451-5
- Fogari, R, Zoppi, A, Tettamanti, F, Malamani, GD, Tinelli, C, Salvetti, A (1992) Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 19: pp. 670-3 CrossRef
- Tenenbaum, A, Grossman, E, Shemesh, J, Fisman, EZ, Nosrati, I, Motro, M (2000) Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 13: pp. 776-82 CrossRef
- Knox, AJ, Pang, L (1997) Tackling ACE inhibitor cough. Lancet 350: pp. 814-814 CrossRef
- Tu, JV, Naylor, CD (1997) Clinical prediction rules. J Clin Epidemiol 50: pp. 743-4 CrossRef
- Metz, CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8: pp. 283-98
- Laupacis, A, Sekar, N, Stiell, IG (1997) Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277: pp. 488-94 CrossRef
- Bates, DW, Lee, TH (1992) Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm. JAMA 267: pp. 1962-6 CrossRef
- Bates, DW, Leape, LL, Cullen, DJ (1998) Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280: pp. 1311-6 CrossRef
- Raschke, RA, Gollihare, B, Wunderlich, TA (1998) A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 280: pp. 1317-20 CrossRef
- Wang SJ, Kuperman GJ, Ohno-Machado L, Onderdonk A, Sandige H, Bates DW. Using electronic data to predict the probability of true bacteremia from positive blood cultures. Proc AMIA Symp. 2000:893–7.
- Goldman, L, Cook, EF, Brand, DA (1988) A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 318: pp. 797-803 CrossRef
- Goldman, L, Cook, EF, Johnson, PA, Brand, DA, Rouan, GW, Lee, TH (1996) Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med 334: pp. 1498-504 CrossRef
- Bates, DW, Ebell, M, Gotlieb, E, Zapp, J, Mullins, HC (2003) A proposal for electronic medical records in U.S. primary care. J Am Med Inform Assoc 10: pp. 1-10 CrossRef
- Randolph, AG, Guyatt, GH, Calvin, JE, Doig, G, Richardson, WS (1998) Understanding articles describing clinical prediction tools. Evidence Based Medicine in Critical Care Group. Crit Care Med 26: pp. 1603-12 CrossRef
- Development and validation of a Clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough
Journal of General Internal Medicine
Volume 19, Issue 6 , pp 684-691
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- adverse drug events
- angiotensin-converting enzyme inhibitors
- clinical prediction rule
- Industry Sectors
- Author Affiliations
- 1. Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, 75 Francis Street, 02115, Boston, MA
- 2. Harvard School of Public Health, Boston, Mass
- 3. Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
- 4. Harvard Medical School, Boston, Mass